Multimodal approach predicts relapse upon cessation of immune checkpoint inhibitors in advanced melanoma. Noh KW, Tolkach Y, Helbig D, Mitchell Barroso V, et al. Clin Cancer Res 2025 Aug 25. doi: 10.1158/1078-0432.CCR-25-0889.

Read + Share

Amedeo Smart

Independent Medical Education

Noh KW, Tolkach Y, Helbig D, Mitchell Barroso V, et al. Multimodal approach predicts relapse upon cessation of immune checkpoint inhibitors in advanced melanoma. Clin Cancer Res 2025 Aug 25. doi: 10.1158/1078-0432.CCR-25-0889.
PMID: 40853889